← Leaderboards
Daniel Fowler
Clinical Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Sciences
Same institution · by research overlap
- Larry W Kwak$10,852,773
- Jay A Berzofsky$0
- Patrick Hwu$17,535,407
- Michael R Bishop$0
- William Laurence Dahut$0
Others in their field
Top investigators on “Sirolimus”
- Valentin Fuster · Mount Sinai School Of Medicine Of Nyu$24,172,286
- Richard A. Miller · University Of Michigan At Ann Arbor$23,324,608
- Randy Strong · South Texas Veterans Health Care System$17,841,907
- David E Harrison · Jackson Laboratory$16,537,341
- David Michael Briscoe · Children'S Hospital Boston$16,289,072
- David M Sabatini · Whitehead Institute For Biomedical Res$16,271,502
Research focus
SirolimusT-LymphocyteAllogenicGraft-Vs-Host DiseaseHematopoietic Stem Cell TransplantationCellsIn VivoLeukemia/LymphomaBone Marrow TransplantationClinical TrialsT-Lymphocyte SubsetsResistanceMediatingClinical ProtocolsApoptosisAnimal ModelReactionUniversitiesComplicationImmunePharmaceutical PreparationsUnited States National Institutes Of HealthCell TherapyHomologous Transplantation
Grant awards (36)
Th1-Th2 and Tc1-Tc2 T Cell Subsets in Transplantation Therapy$758,451
ZIA · FY2017 · CA · contact PI
Understanding T Cell Rapamycin Resistance$379,226
ZIA · FY2017 · CA · contact PI
Combination Gene Therapy and Th1-Th2 Therapy$379,226
ZIA · FY2017 · CA · contact PI
Th1-Th2 and Tc1-Tc2 T Cell Subsets in Transplantation Therapy$736,109
ZIA · FY2016 · CA · contact PI
Understanding T Cell Rapamycin Resistance$368,054
ZIA · FY2016 · CA · contact PI
Combination Gene Therapy and Th1-Th2 Therapy$368,054
ZIA · FY2016 · CA · contact PI
Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy$734,808
ZIA · FY2015 · CA · contact PI
Combination Gene Therapy and Th1Th2 Therapy$367,403
ZIA · FY2015 · CA · contact PI
Understanding T Cell Rapamycin Resistance$367,403
ZIA · FY2015 · CA · contact PI
Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy$766,002
ZIA · FY2014 · CA · contact PI
Combination Gene Therapy and Th1Th2 Therapy$383,001
ZIA · FY2014 · CA · contact PI
Understanding T Cell Rapamycin Resistance$383,001
ZIA · FY2014 · CA · contact PI
Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy$627,158
ZIA · FY2013 · CA · contact PI
Combination Gene Therapy and Th1Th2 Therapy$313,579
ZIA · FY2013 · CA · contact PI
Understanding T Cell Rapamycin Resistance$313,579
ZIA · FY2013 · CA · contact PI
Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy$672,235
ZIA · FY2012 · CA · contact PI
Combination Gene Therapy and Th1Th2 Therapy$336,118
ZIA · FY2012 · CA · contact PI
Understanding T Cell Rapamycin Resistance$336,118
ZIA · FY2012 · CA · contact PI
Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy$591,928
ZIA · FY2011 · CA · contact PI
Understanding T Cell Rapamycin Resistance$295,964
ZIA · FY2011 · CA · contact PI
Combination Gene Therapy and Th1Th2 Therapy$295,964
ZIA · FY2011 · CA · contact PI
Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy$714,516
ZIA · FY2010 · CA · contact PI
Understanding T Cell Rapamycin Resistance$357,257
ZIA · FY2010 · CA · contact PI
Combination Gene Therapy and Th1Th2 Therapy$357,257
ZIA · FY2010 · CA · contact PI
Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy$651,280
ZIA · FY2009 · CA · contact PI
Combination Gene Therapy and Th1Th2 Therapy$325,640
ZIA · FY2009 · CA · contact PI
Understanding T Cell Rapamycin Resistance$325,640
ZIA · FY2009 · CA · contact PI
Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy$1,256,076
Z01 · FY2008 · CA · contact PI
Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy$1,985,262
Z01 · FY2007 · CA · contact PI
Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Ther$0
Z01 · FY2006 · SC · contact PI
Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Ther$0
Z01 · FY2005 · SC
Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation$0
Z01 · FY2004 · SC
Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation Th$0
Z01 · FY2003 · SC
Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation Th$0
Z01 · FY2002 · SC
Th1/Th2 &Tc1/Tc2 T Cell Subsets in Transplantation Ther$0
Z01 · FY2001 · SC
Autologous and Allogeneic T Cell Strategies for the Treatment of Hematologic Mal$0
Z01 · FY2000 · SC